LENTIVECTOR

Welcome to the Brand page for “LENTIVECTOR”, which is offered here for Material treatment, chemical synthesis for others featuring the development of a process to manufacture ingredients or finished biochemical products for applications in biotechnology;clinical medical reagents for use in gene therapy; pharmaceutical preparations for use in gene therapy; therapeutic compositions containing liposome reagents suitable for gene therapy; therapeutic compositions containing nucleic acid for gene therapy; pharmaceutical preparations containing nucleic acid for a system delivering genes to non-dividing cells for use in the treatment of viral and bacterial infections, cancer, hiv and aids related infections, leukemia and bodily conditions associated with impaired immunosystem;chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals and retroviral vector preparations;medical services;scientific and medical research and development; genetic engineering services, biotechnology services, research and development of new products in the field of biotechnology;.

Its status is currently believed to be active. Its class is unavailable. “LENTIVECTOR” is believed to be currently owned by “Oxford BioMedica plc”.